Intellipharmaceutics International Incorporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Intellipharmaceutics International Incorporation with three other
companies in this sector in CANADA :
Polydex Pharmaceuticals Limited
(2019
sales of 6.46 million Canadian Dollars [US$4.55 million]
),
IntelGenx Technologies Corp.
(981,806.98 Canadian Dollars [US$691,899.01 ]
), and
Acerus Pharmaceuticals Corporation
(4.99 million Canadian Dollars [US$3.51 million]
of which 100%
was Pharmacueticals).
Sales Analysis.
Intellipharmaceutics International Incorporation reported sales of C$4.62 million (US$3.26 million)
for the
fiscal
year ending
November of 2019.
This
represents
an
increase of 109.2%
versus 2018, when the company's sales were C$2.21 million.
Despite this increase, sales are still
well
below the level achieved in 2017, when Intellipharmaceutics International Incorporation
reported sales of C$7.17 million.